Page 97 - Read Online
P. 97

Page 227                   Xu et al. J Transl Genet Genom 2021;5:218-39  https://dx.doi.org/10.20517/jtgg.2021.20
















































                                                                                        [140]
                Figure 2. Genetic variants associated with ALL risk and outcomes across the genome. PhenoGram plots   were constructed for
                genetic variants associated with (A) ALL susceptibility, and/or (B) ALL patient outcomes (i.e., relapse and response to therapy).
                Genetic variants included in the PhenoGrams were identified in the NHGRI-EBI catalog of human genome-wide association studies
                (GWAS Catalog) [141]  and included in published GWAS for acute lymphoblastic leukemia (ALL) [15,16,18-20,24-27,32,135,136]  or for outcomes of
                ALL [142-150] . We also included some variants described in additional papers included in this review for ALL susceptibility [17,21-23,28-31]  and
                ALL patient outcomes [21,139] . For ALL susceptibility (A) we only included variants that passed genome-wide significance levels of P < 5 ×
                 -8
                                                                                         -8
                10 . For patient outcomes (B), we included variants that passed genome-wide significance levels of P < 5 × 10  plus variants in GATA3
                and ARID5B from gene-specific analyses. Lines are plotted on each chromosome corresponding to the base-pair position of each single
                nucleotide polymorphism (SNP). Variants are colored by related phenotypes that have been detected in GWAS (from the “Reported
                trait” column in the GWAS Catalog). Shapes of variants correspond to the genetic ancestry (if any) that has been associated with the
                SNP risk allele. N/A represents no related ancestry has been reported so far.
               ancestry [29,31] . Together, risk loci in ARID5B, GATA3, PIP4K2A, CEBPE, and ERG likely account for some of
               the observed differences in ALL incidence between Hispanics/Latinos and non-Hispanic/Latino
               races/ethnicities, which may be partly explained by the Indigenous American ancestry in Hispanics/Latinos.
               Indeed,  it  has  been  suggested  that  the  CEBPE, ARID5B, and  GATA3  risk  SNPs  may  account  for
               approximately  3%,  11%,  and  11%  increased  risk  of  B-ALL  in  Hispanics/Latinos  vs.  NHWs,
               respectively [137,138] . Intriguingly, a recent study found that Indigenous American ancestry increased by ~20%
               on average in Mexican Americans in the United States during the 1940s-1990s, partly attributable to
               assortative mating, shifts in migration pattern and changes in population size . Given the association
                                                                                    [151]
               between ALL risk alleles and Indigenous American ancestry, this perhaps suggests that this shift in genetic
               ancestry may contribute to the rising ALL incidence among Hispanics/Latinos, although this warrants
   92   93   94   95   96   97   98   99   100   101   102